临床试验监查计划(TMP)新模板:德尔菲流程产出
该研究旨在通过整合临床试验监查经验丰富人员的意见,创建临床试验监查计划(TMP)模板。研究基于英国临床研究协作组织(UKCRC)注册临床试验单位(CTU)的31份监查计划初步拟定模板,经两轮德尔菲调查(47名参与者,来自25个UK CTU及产业界)和共识会议(9名参与者,来自9个UK CTU及产业界)最终确定纳入模板的条目。最终形成标准化TMP模板,预期有助于维持各CTU监查标准的一致性,提升研究质量与质量保证。
要点
- 基于31份UKCRC注册CTU的监查计划及800余项监查条目拟定初步TMP模板。
- 两轮德尔菲调查后37项条目达成纳入共识,共识会议投票排除18项、纳入14项。
- 最终TMP模板由具备临床试验监查经验或专长的人员输入形成。
核心结论
- 在现有监查计划基础上,结合临床试验监查经验丰富人员的输入,开发了TMP模板。
- 使用集中开发的优质TMP模板应有助于维持所有CTU监查标准的一致性,从而提升研究质量和质量保证。
研究设计与样本
- 基于UKCRC注册CTU的31份监查计划评审拟定初步TMP模板,经两轮德尔菲调查和两部分共识会议最终确定模板。
- 德尔菲调查参与者47名,来自25个UK CTU及产业界;共识会议参与者9名,来自9个UK CTU及产业界。
主要发现
- 从UKCRC注册CTU收到31份监查计划,评审了超过800项监查条目以供纳入TMP模板。
- 首轮德尔菲调查后全部66项条目保留,德尔菲参与者另建议6项条目。
- 第二轮德尔菲调查中37项条目达成纳入TMP模板的共识。
- 共识会议对德尔菲中未达共识定义的32项进一步条目投票,结果18项被排除,14项纳入TMP模板。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Monitoring is a crucial part of trial conduct and ensures that participants' data is fairly represented, and future healthcare information is enhanced. This project aims to improve trial monitoring by creating a trial monitoring plan (TMP) template with input from individuals experienced in monitoring clinical trials. METHODS: A review of monitoring plans received from UK Clinical Research Collaboration (UKCRC) registered clinical trials units (CTU)s created the basis for a preliminary TMP template and a Delphi survey. The TMP template was finalised after 2 rounds of a Delphi survey and a two-part consensus meeting including trialists with experience and expertise in monitoring clinical trials. RESULTS: We received 31 monitoring plans from UKCRC-registered CTUs and reviewed over 800 monitoring items for inclusion in a TMP template, selecting items based on guidelines such as Good Clinical Practice (GCP) and our monitoring experiences. For certain items, further expert input was required. A total of 66 items were chosen for a Delphi survey involving 47 participants from 25 UK CTUs and industry. After the first round, all 66 items were retained, and six additional items were suggested by Delphi participants. In the second round, 37 items reached consensus for inclusion in the TMP template. The Delphi process was followed by a consensus meeting with 9 participants from 9 UK CTUs and industry. Participants in the consensus meeting voted on the 32 further items that had not reached the definition of consensus within the Delphi, regarding each item's inclusion in or exclusion from the TMP template. The voting resulted in 18 items being excluded, leaving 14 items to be included in the TMP template. The process overall resulted in a standardised TMP template with input from many individuals with interest, experience, or expertise in monitoring clinical trials. CONCLUSION: A TMP template was developed building on the currently used monitoring plans and with input from those experienced in clinical trial monitoring. Using a centrally developed good quality TMP template should contribute towards maintaining consistency in monitoring standards across all CTUs, resulting in higher research quality and improved quality assurance. Its use should provide reassurance to participants that their participation is carefully monitored to ensure that their data or any samples provided are treated with confidentiality, integrity, and respect and that their rights and well-being are protected.
引用
- Taheri S, Yorke-Edwards V, Sydes MR, et al. A new trial monitoring plan (TMP) template for clinical trials: output from a Delphi process. Trials. 2024. PMID: 39516824. doi:10.1186/s13063-024-08601-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。